SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 19th, 2010 • Cryolife Inc • Surgical & medical instruments & apparatus • Georgia
This SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) originally dated as of the 4th day of November, 2008, as amended on November 2, 2009 (the “Effective Date”), is by and between CRYOLIFE, INC., a Florida corporation (“CryoLife”, or the “Company”) and STEVEN G. ANDERSON (the “Employee”).
CONFIDENTIAL TREATMENT REQUESTED [***] – CONFIDENTIAL PORTIONS OF THIS AGREEMENT WHICH HAVE BEEN REDACTED ARE MARKED WITH BRACKETS (“[***]”). THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION....Credit Agreement • February 19th, 2010 • Cryolife Inc • Surgical & medical instruments & apparatus • New York
THIS SECOND AMENDMENT TO CREDIT AGREEMENT (“Amendment”) is entered into as of November 9, 2009, by and among CryoLife, Inc., a Florida corporation (“CryoLife”), CryoLife Acquisition Corporation, a Florida corporation (“Acquisition Corp”), AuraZyme Pharmaceuticals, Inc., a Florida corporation (“AuraZyme”), CryoLife International, Inc., a Florida corporation (“International”) (CryoLife, Acquisition Corp, International and AuraZyme are sometimes referred to herein together as the “Borrowers” and individually as a “Borrower”), CryoLife, as Borrower Representative, the other Persons party hereto that are designated as a “Credit Party”, General Electric Capital Corporation, a Delaware corporation (the “Agent”), as administrative agent for the several financial institutions from time to time party to this Amendment (collectively, the “Lenders” and individually each a “Lender”) and for itself as a Lender and L/C Issuer, and such Lenders.
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • February 19th, 2010 • Cryolife Inc • Surgical & medical instruments & apparatus • New York
THIS FIRST AMENDMENT TO CREDIT AGREEMENT (“Amendment”) is entered into as of May 7, 2009, by and among CryoLife, Inc., a Florida corporation (“CryoLife”), CryoLife Acquisition Corporation, a Florida corporation (“Acquisition Corp”), AuraZyme Pharmaceuticals, Inc., a Florida corporation (“AuraZyme”), CryoLife International, Inc., a Florida corporation (“International”) (CryoLife, Acquisition Corp, International and AuraZyme are sometimes referred to herein together as the “Borrowers” and individually as a “Borrower”), CryoLife, as Borrower Representative, the other Persons party hereto that are designated as a “Credit Party”, General Electric Capital Corporation, a Delaware corporation (the “Agent”), as administrative agent for the several financial institutions from time to time party to this Amendment (collectively, the “Lenders” and individually each a “Lender”) and for itself as a Lender and L/C Issuer, and such Lenders.
